Thiazide and thiazide-like diuretics
A group of diuretics used for high blood pressure and for swelling from fluid build-up. The US label read for hydrochlorothiazide, a thiazide, lists high blood pressure and fluid build-up from congestive heart failure. The label read for chlorthalidone, which the label says differs chemically from the thiazides, lists the same two uses, and the US drug record places it in a thiazide-like group.
Also called Thiazide diuretics · Thiazide-like diuretics · Thiazides
- Drug
- In this atlas
Overview
Technical summary
Class page for a group made of two sets. MeSH descriptor D049993 (Sodium Chloride Symporter Inhibitors, last updated 2021-06-30) is a broad match: it is named for the mechanism, agents that inhibit sodium chloride symporters and act as diuretics, and it holds a concept for thiazide diuretics (Diuretics, Thiazide). The chemical descriptor D049971 (Thiazides) is not used as the match, because MeSH defines it as heterocyclic compounds, commonly the benzothiadiazines, so it does not cover the thiazide-like members. Two US labels were read: hydrochlorothiazide tablets (application ANDA202556, effective 2026-04-01 in openFDA; established pharmacologic class Thiazide Diuretic) and chlorthalidone tablets (application ANDA211627, effective 2022-11-24 in openFDA; established pharmacologic class Thiazide-like Diuretic). Both are generic labels, not the original brand. The hydrochlorothiazide label says the mechanism of the antihypertensive effect of thiazides is unknown. The label texts read state no age range for their uses. This page gives no dose, no trial result and no guideline statement; the pregnancy and other warnings in the labels were not recorded. Medicines of the group that have their own pages are filed under it.
Trials at a glance
The figures count the 5 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.
- Trials
- 5
- Phase 3 or 4
- 4
- Recruiting
- 0
- Regulatory decisions
- 0
| Phase | Completed | Terminated | All statuses |
|---|---|---|---|
| Phase 2 | 1 | 0 | 1 |
| Phase 3 | 2 | 1 | 3 |
| Phase 4 | 1 | 0 | 1 |
| All phases | 4 | 1 | 5 |
Conditions these trials study
Sponsors with the most trials
- Indiana University
- Spanish Society of Internal Medicine
- The University of Texas Medical Branch, Galveston
- VA Office of Research and Development
- West China Hospital
Drugs in this class
3 drugs in this atlas are filed under Thiazide and thiazide-like diuretics, with the registry trials and FDA regulatory decisions this atlas holds for each. With Thiazide and thiazide-like diuretics itself, the class has 24 distinct trials and 69 distinct FDA decisions; a trial or decision that two of them share counts once there.
About this drug
- Level
- Class
- Mechanism
- The hydrochlorothiazide label says the mechanism of the antihypertensive effect of thiazides is unknown, and that the medicine affects the distal renal tubular mechanism of electrolyte reabsorption.
Classification codes
-
D049993Sodium Chloride Symporter Inhibitors
Claims and evidence
Context People with hypertension or with edema from congestive heart failure, as described in two US labels of a thiazide and a thiazide-like diuretic
- Recipient
- Recipient not specified
- Population
- Patients described in the indications sections of the two labels: patients with hypertension, and patients with edema associated with congestive heart failure (among other causes the labels list).
- Care setting
- Prescription medicine, as described in the US labels
- Geography
- United States (US drug labels)
- Life stage
- Not stated in the passages read
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (label statement)
Eligibility: 2 inclusion criteria; exclusion criteria not stated
- Included
- Hypertension
- Edema associated with congestive heart failure
- Excluded
- None stated
Two US generic labels were read. The label of hydrochlorothiazide tablets (Accord Healthcare Inc., application ANDA202556; the version dated 2026-04-01 in openFDA) calls the medicine a diuretic and antihypertensive and lists the management of hypertension and adjunctive therapy in edema associated with congestive heart failure. The label of chlorthalidone tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA211627; the version dated 2022-11-24 in openFDA) calls the medicine a monosulfamyl diuretic that differs chemically from thiazide diuretics, and lists the management of hypertension and the same heart failure edema use. openFDA's records give the established pharmacologic class Thiazide Diuretic for the first label and Thiazide-like Diuretic for the second. MeSH says the thiazide term commonly refers to the benzothiadiazines used as diuretics. It files thiazide diuretics as a concept of the descriptor Sodium Chloride Symporter Inhibitors, agents that act as diuretics.
Applies to Recipient not specified People with hypertension or with edema from congestive heart failure, as described in two US labels of a thiazide and a thiazide-like diuretic
- Certainty method
- Not assessed
- Limitations
- This claim records what two US generic labels say. It is not a finding about how well either medicine works, and no trial result is recorded for it in this atlas. The pharmacologic class names come from openFDA's record of each label. The labels list other uses and a pregnancy statement that were not recorded; contraindications, other warnings, interactions and dosing were not recorded either. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked
- 2026-11-09
- Next evidence check due
- Not scheduled
Sources and citations (10)
-
- Locator
- results[0].indications_and_usage[0], INDICATIONS AND USAGE
- How it applies
- Hydrochlorothiazide: hypertension and heart failure edema.
- Retrieved
- Source effective date
- 2026-04-01
- Source state
- Current
- Version fingerprint
84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].openfda.pharm_class_epc[0]
- How it applies
- Established pharmacologic class in openFDA: Thiazide Diuretic.
- Retrieved
- Source effective date
- 2026-04-01
- Source state
- Current
- Version fingerprint
84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].effective_time
- How it applies
- Effective date of the label text read, 20260401.
- Retrieved
- Source effective date
- 2026-04-01
- Source state
- Current
- Version fingerprint
84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].indications_and_usage[0], INDICATIONS AND USAGE
- How it applies
- Chlorthalidone: hypertension and heart failure edema.
- Retrieved
- Source effective date
- 2022-11-24
- Source state
- Current
- Version fingerprint
5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].description[0], DESCRIPTION
- How it applies
- Chlorthalidone differs chemically from thiazide diuretics.
- Retrieved
- Source effective date
- 2022-11-24
- Source state
- Current
- Version fingerprint
5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].openfda.pharm_class_epc[0]
- How it applies
- Established pharmacologic class in openFDA: Thiazide-like Diuretic.
- Retrieved
- Source effective date
- 2022-11-24
- Source state
- Current
- Version fingerprint
5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].effective_time
- How it applies
- Effective date of the label text read, 20221124.
- Retrieved
- Source effective date
- 2022-11-24
- Source state
- Current
- Version fingerprint
5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
Supports MeSH scope note for descriptor D049971 (Thiazides)
- Locator
- scopeNote.@value
- How it applies
- MeSH scope note: what the thiazide term refers to.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
8f55829c320bca01d90bd277a7bba2f780bac3669a7cd29cf94af0e707c25da1- Reuse basis
- The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
-
Supports MeSH scope note for descriptor D049993 (Sodium Chloride Symporter Inhibitors)
- Locator
- scopeNote.@value
- How it applies
- MeSH scope note of the matched descriptor: sodium chloride symporter inhibitors act as diuretics.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
a43244ed8eef72fe5a73e6d72636c10c164cd63eb440860890bb960d19857b07- Reuse basis
- The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
-
- Locator
- label.@value
- How it applies
- MeSH concept of the matched descriptor named Diuretics, Thiazide.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
7119cc10d5b13289e5912295254fa99e0ea0c9a5ef96985ca56463f13bc7d0d4- Reuse basis
- The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Two US labels list managing high blood pressure as an indication: Hypertension (high blood pressure)
Applies to Recipient not specified People with hypertension or with edema from congestive heart failure, as described in two US labels of a thiazide and a thiazide-like diuretic
Two US generic labels were read. The label of hydrochlorothiazide tablets (Accord Healthcare Inc., application ANDA202556; the version dated 2026-04-01 in openFDA) calls the medicine a diuretic and antihypertensive and lists the management of hypertension and adjunctive therapy in edema associated with congestive heart failure. The label of chlorthalidone tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA211627; the version dated 2022-11-24 in openFDA) calls the medicine a monosulfamyl diuretic that differs chemically from thiazide diuretics, and lists the management of hypertension and the same heart failure edema use. openFDA's records give the established pharmacologic class Thiazide Diuretic for the first label and Thiazide-like Diuretic for the second. MeSH says the thiazide term commonly refers to the benzothiadiazines used as diuretics. It files thiazide diuretics as a concept of the descriptor Sodium Chloride Symporter Inhibitors, agents that act as diuretics.Limitations. This claim records what two US generic labels say. It is not a finding about how well either medicine works, and no trial result is recorded for it in this atlas. The pharmacologic class names come from openFDA's record of each label. The labels list other uses and a pregnancy statement that were not recorded; contraindications, other warnings, interactions and dosing were not recorded either. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
-
Claim, not a settled fact Two US labels list fluid build-up from congestive heart failure as an indication: Heart failure
Applies to Recipient not specified People with hypertension or with edema from congestive heart failure, as described in two US labels of a thiazide and a thiazide-like diuretic
Two US generic labels were read. The label of hydrochlorothiazide tablets (Accord Healthcare Inc., application ANDA202556; the version dated 2026-04-01 in openFDA) calls the medicine a diuretic and antihypertensive and lists the management of hypertension and adjunctive therapy in edema associated with congestive heart failure. The label of chlorthalidone tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA211627; the version dated 2022-11-24 in openFDA) calls the medicine a monosulfamyl diuretic that differs chemically from thiazide diuretics, and lists the management of hypertension and the same heart failure edema use. openFDA's records give the established pharmacologic class Thiazide Diuretic for the first label and Thiazide-like Diuretic for the second. MeSH says the thiazide term commonly refers to the benzothiadiazines used as diuretics. It files thiazide diuretics as a concept of the descriptor Sodium Chloride Symporter Inhibitors, agents that act as diuretics.Limitations. This claim records what two US generic labels say. It is not a finding about how well either medicine works, and no trial result is recorded for it in this atlas. The pharmacologic class names come from openFDA's record of each label. The labels list other uses and a pregnancy statement that were not recorded; contraindications, other warnings, interactions and dosing were not recorded either. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 5
Record details
- Record id
cardio:thiazide-and-thiazide-like-diuretics- Content hash
6efd2718f01e794731d09599c48c12e0fb7599e4d5fc85389bcf8fc94874c4bf